Scott Gottlieb prepares to leave the FDA after accomplishing much.

A key focus of Andrew McLachlan’s career is understanding the impact of aging on drug disposition and response to medicines.

Vote now for the top drug development technology of 2018.

EFPIA figures give a snapshot of drug development and innovation in Europe. Check out our infographic for some of the key stats.

The inventor of ibuprofen died on January 30, aged 95.

Gene therapy deals, clinical trials transparency and sartan medicine reviews… what’s new for pharma in business?

Conversations around drug pricing look set to continue for years, but the industry is also experiencing fantastic breakthroughs in science.

As ever, our industry will have to deal with its fair share of sociopolitical “fun” in 2019. But what can we do?

How a collaborative project aims to cut the cost of gene therapy

Mega mergers, state-of-the-art stem cell facility and humorous pharmaceutical ads… What’s new for pharma in business?